RAPH · Forms 3, 4, 5
Insider trades at Raphael Pharmaceutical Inc.
No open-market insider buys or sells at Raphael Pharmaceutical Inc. in the last 90 days; 6 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Raphael Pharmaceutical Inc. (RAPH) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Raphael Pharmaceutical Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Hayon Igal Louria | Chief Technology Officer | Option exercise | 350,000 | $0.01 | $4K | Form 4 | |
| Zvi Laufer Laor | Director | Became an insider (Form 3) | Form 3 | ||||
| Yehuda Eliya | Director | Options or other derivatives | Form 4 | ||||
| Ajay Kumar Dhadha | Director | Award | 350,000 | Form 4 | |||
| Shlomo Pilo | Chief Executive Officer | Award | 200,000 | $0.50 | $100K | Form 4 | |
| Ajay Kumar Dhadha | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.